cardiovascular diseases

Summary

Summary: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Webpages

  1. who | health topics
    www.who.int/health_topics/en/
  2. medlineplus: health topics beginning with c
    www.nlm.nih.gov/medlineplus/healthtopics_c.html
  3. no title
    www.utmem.edu/pharmacology/faculty/malik.html
  4. find a doctor
    www.bronsonhg.org/FindADoctor/FindADoctorForm.jsp
  5. nih - women's health
    health.nih.gov/category/WomensHealth
  6. houston hospital | largest texas hospital system | memorial hermann healthcare system | houston, tx
    www.mhhs.org
  7. hardin library simulation center - the university of iowa libraries
    www.lib.uiowa.edu/hardin/simulation/equipment.html
  8. vumc research; display faculty
    medschool.mc.vanderbilt.edu/facultydata/php_files/part_dept/ ...
  9. st. boniface general hospital research centre - dr. karmin o
    www.sbrc.ca/content/blogcategory/80/124/index.html
  10. no title
    www.utmem.edu/pharmacology/faculty/elam.html

Research Grants

  1. Sub-Clinical Coronary Artery Disease in South Asian Immigrants: Determination of
    Sunita Dodani; Fiscal Year: 2008
  2. Clinical Research and Mentoring in Oral Epidemiology
    Kaumudi J Joshipura; Fiscal Year: 2008
  3. Clinical Research and Mentoring in Oral Epidemiology
    Kaumudi J Joshipura; Fiscal Year: 2007
  4. THE AGING GENOME ASSOCIATION STUDY ? ?AGE-GAIN?
    Luigi Ferrucci; Fiscal Year: 2006
  5. Structural Biology of the Apical Bile Acid Transporter.
    Peter W Swaan; Fiscal Year: 2008
  6. Rac, Superoxide and Antioxidants in Hypertension
    Pascal J Goldschmidt-Clermont; Fiscal Year: 2005
  7. ROS in Pulmonary Hypertension: Role of ADMA
    Stephen M Black; Fiscal Year: 2008
  8. Myosin Phosphatase Regulation in Vascular Smooth Muscle
    Howard K Surks; Fiscal Year: 2008
  9. Fish Oil in Pregnancy and Offspring CVD Risk: 17 years follow-up from an RCT
    SJURDUR FRODI sfo@sociaudk OLSEN; Fiscal Year: 2008
  10. Longevity foods, SIRT activation and diabetic dyslipidemia.
    Pratibha V Nerurkar; Fiscal Year: 2007

Publications

  1. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2)
    Bernard M Y Cheung
    Department of Medicine, University of Hong Kong, Hong Kong
    Am J Hypertens 21:17-22
  2. Metabolic and cardiovascular effects of smokeless tobacco
    Ziad Arabi
    Department of General Internal Medicine, Geriatrics and Health Policy Research, University of Louisville, Louisville, KY 41729, USA
    J Cardiometab Syndr 1:345-50
  3. Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II)
    Prakash C Deedwania
    University of California San Francisco, School of Medicine, Fresno, CA 93703, USA
    J Cardiometab Syndr 1:295-300
  4. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by r
    Ian Graham
    Department of Cardiology, The Adelaide and Meath Hospital, Tallaght, Doublin, Ireland
    Eur J Cardiovasc Prev Rehabil 14:E1-40
  5. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by represent
    Ian Graham
    Department of Cardiology, The Adelaide and Meath Hospital, Tallaght, Dublin, Ireland
    Eur J Cardiovasc Prev Rehabil 14:S1-113
  6. Association of age and sex with cardiovascular risk factors and insulin sensitivity in overweight children and adolescents
    Joanna Koenigsberg
    Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA
    J Cardiometab Syndr 1:253-8
  7. Accuracy of anthropometric indicators of obesity to predict cardiovascular risk
    Harald J Schneider
    Institute of Clinical Psychology and Psychotherapy, Technical University, Dresden, Germany
    J Clin Endocrinol Metab 92:589-94
  8. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence
    Yoshifusa Aizawa
    Niigata University Graduate School of Medical and Dental Science Division of Cardiology, Japan
    Int J Cardiol 109:213-8
  9. Morphological and functional changes of cardiovascular system in postmenopausal women
    N Alessandri
    Dipartimento del Cuore e Grossi Vasi A Reale U O S Cardiology Polo Pontino, University of Rome La Sapienza, Rome, Italy
    Eur Rev Med Pharmacol Sci 11:107-17
  10. Prevalence of the main cardiovascular risk factors in Morocco: results of a National Survey, 2000
    Mohammed A Tazi
    Directorate of Epidemiology and Control Diseases, Health Ministry, Rabat, Morocco
    J Hypertens 21:897-903

Scientific Experts

Detail Information

Webpages113 found, 30 most recent shown here

  1. who | health topics
    www.who.int/health_topics/en/
  2. medlineplus: health topics beginning with c
    www.nlm.nih.gov/medlineplus/healthtopics_c.html
  3. no title
    www.utmem.edu/pharmacology/faculty/malik.html
  4. find a doctor
    www.bronsonhg.org/FindADoctor/FindADoctorForm.jsp
  5. nih - women's health
    health.nih.gov/category/WomensHealth
  6. houston hospital | largest texas hospital system | memorial hermann healthcare system | houston, tx
    www.mhhs.org
  7. hardin library simulation center - the university of iowa libraries
    www.lib.uiowa.edu/hardin/simulation/equipment.html
  8. vumc research; display faculty
    medschool.mc.vanderbilt.edu/facultydata/php_files/part_dept/ ...
  9. st. boniface general hospital research centre - dr. karmin o
    www.sbrc.ca/content/blogcategory/80/124/index.html
  10. no title
    www.utmem.edu/pharmacology/faculty/elam.html
  11. glossary - cardiovascular diseases - university of chicago medical center
    www.uchospitals.edu/online-library/content=P00222
  12. uw-madison school of veterinary medicine - academic departments
    www.vetmed.wisc.edu/people/henikr
  13. podiatry consumer brochure
    www.op.nysed.gov/podb.htm
  14. lipids and cell signalling - dr alan sneddon
    www.rowett.ac.uk/divisions/vhp/a_sneddon.html
  15. opening the lid on today’s heart medications
    www.palmettohealth.org/body-NoRightMenu.cfm?xyzpdqabc=0&id=3 ...
  16. the therapy of hypertension
    www.mc.uky.edu/pharmacology/instruction/pha824hy/PHA824hy.ht ...
  17. portal to protistology: economically important protists
    www.uga.edu/~protozoa/portal/economic.html
  18. hyperlipidemia prevention and screening resources
    fsumed-dl.slis.ua.edu/prevmedicine/disease-prevention/cardio ...
  19. find a researcher
    findadoc.med.buffalo.edu/profile/facultyprofile.asp?ht=fd&t= ...
  20. atherosclerosis prevention and screening resources
    cchs-dl.slis.ua.edu/prevmedicine/disease-prevention/cardiova ...
  21. find a physician
    findadoc.med.buffalo.edu/profile/facultyprofile.asp?ht=fd&t= ...
  22. about the centers of excellence - louisiana state university health sciences center new orleans
    lsuhsc.edu/no/research/centers.htm
  23. mcmaster university clinical epidemiology & biostatistics >> salim yusuf
    fhs.mcmaster.ca/ceb/faculty_member_yusuf.htm
  24. the linder lab
    klp.web.med.uni-muenchen.de/linder/public.html
  25. w l a b . g u . s e
    www.wall.gu.se/br/index.shtml
  26. advances in the diagnosis and treatment of hypertension
    heart.uchc.edu/education/cardiocorner/articles/hypertension. ...
  27. w l a b . g u . s e
    www.wall.gu.se/mf/index.shtml
  28. huangen ding
    www.biology.lsu.edu/faculty_listings/fac_pages/hding.html
  29. blood glucose, lipid profile, anthropometric and cardiovascular parameters in normal and obese malaysian adolescents - um digital repository
    eprints.um.edu.my/421/

Research Grants62

  1. Sub-Clinical Coronary Artery Disease in South Asian Immigrants: Determination of
    Sunita Dodani; Fiscal Year: 2008
    DESCRIPTION (provided by applicant): Among cardiovascular diseases, coronary artery disease (CAD) is the leading cause of death in the United States, and South Asians (people whose ancestral origin is in the Indian subcontinent i.e...
  2. Clinical Research and Mentoring in Oral Epidemiology
    Kaumudi J Joshipura; Fiscal Year: 2008
    ..focuses on the relationships between oral conditions, inflammatory markers, nutrition and specific cardiovascular diseases. She has expanded this work to include additional cardiovascular endpoints and pregnancy outcomes, and is ..
  3. Clinical Research and Mentoring in Oral Epidemiology
    Kaumudi J Joshipura; Fiscal Year: 2007
    ..focuses on the relationships between oral conditions, inflammatory markers, nutrition and specific cardiovascular diseases. She has expanded this work to include additional cardiovascular endpoints and pregnancy outcomes, and is ..
  4. THE AGING GENOME ASSOCIATION STUDY ? ?AGE-GAIN?
    Luigi Ferrucci; Fiscal Year: 2006
    ..of biological variables and by usingas outcomes the age-specific incidence of critical diseases (cardiovascular diseases, dementia, fractures etc...
  5. Structural Biology of the Apical Bile Acid Transporter.
    Peter W Swaan; Fiscal Year: 2008
    ..it may aid future development of specific therapeutic strategies against hypercholesterolemia and related cardiovascular diseases. PUBLIC HEALTH RELEVANCE: Bile acids play an invaluable role in the intestinal absorption of food-derived ..
  6. Rac, Superoxide and Antioxidants in Hypertension
    Pascal J Goldschmidt-Clermont; Fiscal Year: 2005
    ..that oxidative stress, a state of excessive reactive oxygen species (ROS) activity, is associated with cardiovascular diseases, such as hypertension...
  7. ROS in Pulmonary Hypertension: Role of ADMA
    Stephen M Black; Fiscal Year: 2008
    ..disrupts these regulatory mechanisms, and is a potential factor in the development of a number of cardiovascular diseases including pulmonary hypertension...
  8. Myosin Phosphatase Regulation in Vascular Smooth Muscle
    Howard K Surks; Fiscal Year: 2008
    ..Abnormalities of vascular tone are a hallmark of atherosclerotic cardiovascular diseases and hypertension...
  9. Fish Oil in Pregnancy and Offspring CVD Risk: 17 years follow-up from an RCT
    SJURDUR FRODI sfo@sociaudk OLSEN; Fiscal Year: 2008
    ..strong tracking from early childhood into adult life and an increasing body of evidence supports that cardiovascular diseases (CVD) have origins in the foetal or neonatal environment...
  10. Longevity foods, SIRT activation and diabetic dyslipidemia.
    Pratibha V Nerurkar; Fiscal Year: 2007
    ..epidemic proportions in the United States and is closely linked to type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVD)...
  11. Longevity foods, SIRT activation and diabetic dyslipidemia.
    PRATIBHA V pratibha@hawaiiedu NERURKAR; Fiscal Year: 2008
    ..epidemic proportions in the United States and is closely linked to type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVD)...
  12. Myosin Phosphatase Regulation in Vascular Smooth Muscle
    Howard K Surks; Fiscal Year: 2007
    ..Abnormalities of vascular tone are a hallmark of atherosclerotic cardiovascular diseases and hypertension...
  13. Peptide-Modified Sulfonated Styrene Block Copolymers for Vascular Applications
    David J Vachon; Fiscal Year: 2008
    ..Overall, more than 6 million hospitalizations occur each year for treatment of cardiovascular diseases. Consequently, the economic impact of cardiovascular diseases on our nation's health care system ..
  14. Psychosocial Factors & Stroke Risk in a Biracial Population
    Susan A Everson-Rose; Fiscal Year: 2008
    ..Depressive symptoms, hostility, and stressful conditions are associated with cardiovascular diseases (CVD), but systematic investigation of these factors in relation to stroke incidence and mortality has ..
  15. Psychosocial Factors & Stroke Risk in a Biracial Population
    Susan A Everson-Rose; Fiscal Year: 2007
    ..Depressive symptoms, hostility, and stressful conditions are associated with cardiovascular diseases (CVD), but systematic investigation of these factors in relation to stroke incidence and mortality has ..
  16. Reactive nitrogen species & accelerated atherosclerosis
    Ming-Hui Zou; Fiscal Year: 2007
    ..oxide (NO) of endothelial nitric oxide synthase (eNOS), such as peroxynitrite (ONOO-), are important in cardiovascular diseases including diabetes...
  17. Histo-Mechanics & Biology of Remodeling in Hypertension
    Jay D Humphrey; Fiscal Year: 2005
    DESCRIPTION (provided by applicant): Hypertension remains as a major risk factor for a multitude of cardiovascular diseases, and as such it is responsible for significant morbidity and mortality...
  18. Impact of gastric bypass surgery on risk of CVD in type 2 diabetes mellitus
    Alfonso Torquati; Fiscal Year: 2007
    ..provided by applicant): Patients with type 2 diabetes mellitus (T2DM) are more likely to die from cardiovascular diseases (CVD) than people without diabetes...
  19. NIDDM SUSCEPTIBILITY GENES IN A BIRACIAL COHORT
    Frederick L Brancati; Fiscal Year: 2003
    ..these variants promise to illuminate the pathophysiologic basis of diabetes and diabetes related cardiovascular diseases, accelerate the development of chemopreventive agents, and facilitate the conduct of prevention trials by ..
  20. Genetics of cardiovascular risk factors in large founder population birth control
    Leena Peltonen; Fiscal Year: 2007
    ..This cohort is ideally suited for investigating a) genetic risk factors underlying a wide spectrum of cardiovascular diseases, and b) the relationship between DMA variants and well defined environmental and life style variables...
  21. Genetics of cardiovascular risk factors in large founder population birth control
    Leena Peltonen; Fiscal Year: 2008
    ..This cohort is ideally suited for investigating a) genetic risk factors underlying a wide spectrum of cardiovascular diseases, and b) the relationship between DMA variants and well defined environmental and life style variables...
  22. Triggered Local Release of Active Thrombolytic Agents
    Victor C Yang; Fiscal Year: 2008
    DESCRIPTION (provided by applicant): Cardiovascular diseases, which result from thrombosis of critically situated blood vessels, are a leading cause of deaths...
  23. Point Process Models of Human Heart Beat Interval Dynamics
    Riccardo Barbieri; Fiscal Year: 2008
    ..widely used in research studies, as well as in clinical practice to diagnose both cardiovascular and non-cardiovascular diseases to track its progression and to assess the efficacy of therapies...
  24. Triggered Local Release of Active Thrombolytic Agents
    Victor C Yang; Fiscal Year: 2007
    DESCRIPTION (provided by applicant): Cardiovascular diseases, which result from thrombosis of critically situated blood vessels, are a leading cause of deaths...
  25. Oxidant Stress in the Brain and Hypertension
    Robin L Davisson; Fiscal Year: 2008
    ..Most cardiovascular diseases, notably hypertension, involve pathogenic dysfunction of the autonomic nervous system...
  26. Point Process Models of Human Heart Beat Interval Dynamics
    Riccardo Barbieri; Fiscal Year: 2007
    ..widely used in research studies, as well as in clinical practice to diagnose both cardiovascular and non-cardiovascular diseases to track its progression and to assess the efficacy of therapies...
  27. Image-Guided Non-Invasive Ultrasonic Thrombolysis Using Histotripsy
    Zhen Xu; Fiscal Year: 2008
    ..is the medical term for the process of pathologic blood clot formation, the key mechanism behind many cardiovascular diseases. For example, deep vein thrombosis (DVT) is a condition which affects nearly two million Americans ..
  28. Oxidant Stress in the Brain and Hypertension
    Robin L Davisson; Fiscal Year: 2007
    ..Most cardiovascular diseases, notably hypertension, involve pathogenic dysfunction of the autonomic nervous system...
  29. Mechanisms of Hypertension and Cardiovascular Diseases
    Suzanne Oparil; Fiscal Year: 2008
    DESCRIPTION (provided by applicant): Project Summary This Training Program, Mechanisms of Hypertension and Cardiovascular Diseases, Suzanne Oparil, M.D...
  30. Human serum carbonyl proteome in cardiovascular diseases
    Nisha Jain Garg; Fiscal Year: 2008
    ..These studies will yield potential targets for the development of new drug therapies. Public Health Relevance: This Public Health Relevance is not available...
  31. Regulation of an Iron Import Facilitator by Transcriptional Interference
    CAMILLE REYES NERY; Fiscal Year: 2008
    ..where iron deficiency causes anemia, while an excess of iron results in hemochromatosis, both serious cardiovascular diseases. In Saccharomyces cerevisiae, genes encoding iron transporters and iron uptake facilitators are activated ..
  32. CGMP DEPENDENT PROTEIN KINASE IN VASCULAR BIOLOGY
    Howard K Surks; Fiscal Year: 2003
    Smooth muscle contractile state determines vascular tone, and ischemic and hypertensive cardiovascular diseases arise in part from abnormalities in smooth muscle cell function...
  33. Norepinephrine Transport Regulation By Phosphorylation
    Lankupalle D Jayanthi; Fiscal Year: 2007
    ..Altered NE transport is documented in cardiovascular diseases and brain disorders...
  34. Norepinephrine Transport Regulation By Phosphorylation
    Lankupalle D Jayanthi; Fiscal Year: 2008
    ..Altered NE transport is documented in cardiovascular diseases and brain disorders...
  35. RIGHT VENTRICULAR DYSFUNCTION AND TREATMENT
    Marc J Semigran; Fiscal Year: 2003
    Heart failure represents the results of a variety of cardiovascular diseases in which the initial insult to the myocardium may either be identifiable, such as a myocardial infarction, or unknown, such as in dilated cardiomyopathy...
  36. Transsulfuration and Hyperhomocysteinemia
    RUMA V BANERJEE; Fiscal Year: 2008
    ..Elevated levels of homocysteine constitute a risk factor for cardiovascular diseases, certain neurodegenerative diseases (viz...
  37. Mechanisms of Hypertension and Cardiovascular Diseases
    Suzanne Oparil; Fiscal Year: 2007
    DESCRIPTION (provided by applicant): Project Summary This Training Program, Mechanisms of Hypertension and Cardiovascular Diseases, Suzanne Oparil, M.D...
  38. GENE/DIET EFFECTS ON PLASMA LIPOPROTEIN LEVELS
    Jose M Ordovas; Fiscal Year: 2008
    DESCRIPTION (provided by applicant): Cardiovascular diseases (CVD) are the major causes of morbidity and mortality in the US and their risks are determined by non-modifiable (i.e., genetic) and modifiable factors (i.e...
  39. Transsulfuration and Hyperhomocysteinemia
    RUMA V BANERJEE; Fiscal Year: 2007
    ..Elevated levels of homocysteine constitute a risk factor for cardiovascular diseases, certain neurodegenerative diseases (viz...
  40. GENE-NUTRIENT INTERACTIONS IN REDOX HOMEOSTASIS
    RUMA V BANERJEE; Fiscal Year: 2002
    ..of reactive oxygen species that are implicated in the etiology of multiple and complex diseases such as cardiovascular diseases, Alzheimer's disease, Parkinson's disease, arthritis, certain cancers as well as in aging and apoptosis...
  41. Regulation of Bile Acid Synthesis by Nuclear receptors
    JOHN Y CHIANG; Fiscal Year: 2008
    ..Dysregulation of bile acid metabolism causes dyslipidemia, gallstone, liver, and cardiovascular diseases, and diabetes...
  42. Regulation of Bile Acid Synthesis by Nuclear receptors
    JOHN Y CHIANG; Fiscal Year: 2007
    ..Dysregulation of bile acid metabolism causes dyslipidemia, gallstone, liver, and cardiovascular diseases, and diabetes...
  43. Tissue specific mechanism of FXR in suppressing bile-acid synthesis
    Grace L Guo; Fiscal Year: 2008
    ..Bile acids are involved in liver, biliary, intestinal, and cardiovascular diseases. FXR is a bile-acid activated nuclear receptor and is essential in maintaining bile-acid homeostasis...
  44. TURNING SCAR INTO VIABLE MYOCARDIUM
    Race L Kao; Fiscal Year: 2004
    DESCRIPTION (provided by applicant): Cardiovascular diseases remain the major cause of morbidity and mortality in United States. It is estimated that 12...
  45. Integrative Curriculum for Medicine and Allied Health
    Sara L Warber; Fiscal Year: 2005
    ..interest in CAM education has been accelerated by the work of the NIH-funded CAM Research Center for Cardiovascular Diseases. Strong collaborative relationships have developed within the Medical School, between the Medical School ..
  46. Regulation of Homocysteine-dependent Redox Homeostasis
    RUMA V BANERJEE; Fiscal Year: 2007
    ..to be a common thread connecting the etiologies of various complex and multifactorial diseases, such as cardiovascular diseases, Parkinson's disease, Alzheimer's disease, arthritis and some cancers...
  47. Regulation of Homocysteine-dependent Redox Homeostasis
    RUMA V BANERJEE; Fiscal Year: 2007
    ..to be a common thread connecting the etiologies of various complex and multifactorial diseases, such as cardiovascular diseases, Parkinson's disease, Alzheimer's disease, arthritis and some cancers...
  48. GENE/DIET EFFECTS ON PLASMA LIPOPROTEIN LEVELS
    Jose M Ordovas; Fiscal Year: 2007
    DESCRIPTION (provided by applicant): Cardiovascular diseases (CVD) are the major causes of morbidity and mortality in the US and their risks are determined by non-modifiable (i.e., genetic) and modifiable factors (i.e...
  49. CARDIOVASCULAR DYNAMICS AND THEIR CONTROL
    John E Hall; Fiscal Year: 2008
    ..control systems, and 2) it focuses mainly on long-term control of the circulation because many cardiovascular diseases, such as hypertension, are manifestations of abnormal control mechanisms that develop slowly over long ..
  50. Molecular Genetics of Vascular Disease
    Elizabeth G Nabel; Fiscal Year: 2006
    ..Our focus is on the genetics and genomics of vascular remodeling during common, complex cardiovascular diseases and during premature aging syndromes...
  51. Mechanisms of Electron Transfer in Nitric Oxide Synthases: the Output State in Ni
    Changjian Feng; Fiscal Year: 2007
    ..a critical problem in an increasing number of diseases lacking effective treatments, including cancer and cardiovascular diseases. Before logically designing effective preventive and therapeutic strategies targeting unregulated NO ..
  52. Calcification of Elastin: Mechanisms and Prevention
    Naren R Vyavahare; Fiscal Year: 2008
    ..Elastin degeneration and calcification occurs in a number of cardiovascular diseases including arteriosclerosis, calcific aortic stenosis, bioprosthetic heart valve calcification, human ..
  53. Effects of Statins on AD beyond Cholesterol and Amyloid
    Ling Li; Fiscal Year: 2006
    ..Statins are a class of cholesterol-lowering drugs that have been used successfully to prevent cardiovascular diseases. Recently, retrospective studies have shown an apparent reduction of risk for Alzheimer's disease in ..
  54. Calcification of Elastin: Mechanisms and Prevention
    Naren R Vyavahare; Fiscal Year: 2007
    ..Elastin degeneration and calcification occurs in a number of cardiovascular diseases including arteriosclerosis, calcific aortic stenosis, bioprosthetic heart valve calcification, human ..
  55. Maternal Obesity: A Sheep Model
    JORGE PABLO FIGUEROA; Fiscal Year: 2008
    ..by which fetal adaptations to maternal obesity and/or being born LGA increase the risk for developing cardiovascular diseases. Our global hypothesis is that the offspring of obese mothers have permanent alterations in adipose ..
  56. TRANSCRIPTIONAL REGULATION OF CARDIOMYOCYTE DEVELOPMENT
    Gordon S Huggins; Fiscal Year: 2003
    ..Perturbations of these signaling pathways have been implicated in a number of prevalent human cardiovascular diseases including congenital cardiac malformations, pathologic cardiac hypertrophy, and dilated cardiomyopathy...
  57. Measurement of Sedentary Behavior in African American Adults
    ROBERT LEE NEWTON; Fiscal Year: 2008
    ..risk factor for markers of cardiovascular disease risk (Jakes et al, 2003) and the development of cardiovascular diseases (Sidney et al, 1996)...
  58. Measurement of Sedentary Behavior in African American Adults
    ROBERT LEE NEWTON; Fiscal Year: 2007
    ..risk factor for markers of cardiovascular disease risk (Jakes et al, 2003) and the development of cardiovascular diseases (Sidney et al, 1996)...
  59. Development Modulation of Mouse Uterine Tumorigenesis
    Shuk-Mei Ho; Fiscal Year: 2005
    ..agents has dramatically increased due to the presumed beneficial effects of phytoestrogens in preventing cardiovascular diseases and cancer...
  60. Applied Biosystems 7900HT Fast Real-Time PCR System
    Gordon S Huggins; Fiscal Year: 2007
    ..the Molecular Cardiology Research Institute (MCRI) at the Tufts-New England Medical Center are studying cardiovascular diseases with the goal of identifying new diagnostic tools and treatments that can be used to improve the ..
  61. Virulence factors of periodontopathogens
    Janina P Lewis; Fiscal Year: 2008
    ..In addition, they have been shown to be associated with other health complications such as cardiovascular diseases, diabetes, and preterm low birth weight babies. Both P. gingivalis and Prev...
  62. Virulence factors of periodontopathogens
    Janina P Lewis; Fiscal Year: 2007
    ..In addition, they have been shown to be associated with other health complications such as cardiovascular diseases, diabetes, and preterm low birth weight babies. Both P. gingivalis and Prev...

Publications62

  1. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2)
    Bernard M Y Cheung
    Department of Medicine, University of Hong Kong, Hong Kong
    Am J Hypertens 21:17-22
    ..68-3.17) and 3.48 (95% CI: 2.52-4.81), respectively. CONCLUSIONS: Blood pressure, when not optimal, is the predominant predictor of hypertension. The metabolic syndrome contributes to the risk, especially when blood pressure is optimal...
  2. Metabolic and cardiovascular effects of smokeless tobacco
    Ziad Arabi
    Department of General Internal Medicine, Geriatrics and Health Policy Research, University of Louisville, Louisville, KY 41729, USA
    J Cardiometab Syndr 1:345-50
    ....
  3. Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II)
    Prakash C Deedwania
    University of California San Francisco, School of Medicine, Fresno, CA 93703, USA
    J Cardiometab Syndr 1:295-300
    ..The metabolic syndrome is common in patients receiving lipid-lowering therapy in an office-based setting. Three recent definitions resulted in similar estimates of its prevalence...
  4. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by r
    Ian Graham
    Department of Cardiology, The Adelaide and Meath Hospital, Tallaght, Doublin, Ireland
    Eur J Cardiovasc Prev Rehabil 14:E1-40
  5. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by represent
    Ian Graham
    Department of Cardiology, The Adelaide and Meath Hospital, Tallaght, Dublin, Ireland
    Eur J Cardiovasc Prev Rehabil 14:S1-113
  6. Association of age and sex with cardiovascular risk factors and insulin sensitivity in overweight children and adolescents
    Joanna Koenigsberg
    Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA
    J Cardiometab Syndr 1:253-8
    ..Greater cardiovascular risk factor expression in overweight males 11 years and older may explain the earlier appearance of cardiovascular disease end points in overweight men...
  7. Accuracy of anthropometric indicators of obesity to predict cardiovascular risk
    Harald J Schneider
    Institute of Clinical Psychology and Psychotherapy, Technical University, Dresden, Germany
    J Clin Endocrinol Metab 92:589-94
    ..CONCLUSIONS: There are some indications that WHtR or WC may predict prevalent cardiovascular risk better than BMI or WHR, even though the differences are small...
  8. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence
    Yoshifusa Aizawa
    Niigata University Graduate School of Medical and Dental Science Division of Cardiology, Japan
    Int J Cardiol 109:213-8
    ..These finding suggest that these risk factors do cluster and obesity and insulin resistance were suggested to be linked with metabolic syndrome more than hypertension or high triglyceride...
  9. Morphological and functional changes of cardiovascular system in postmenopausal women
    N Alessandri
    Dipartimento del Cuore e Grossi Vasi A Reale U O S Cardiology Polo Pontino, University of Rome La Sapienza, Rome, Italy
    Eur Rev Med Pharmacol Sci 11:107-17
    ....
  10. Prevalence of the main cardiovascular risk factors in Morocco: results of a National Survey, 2000
    Mohammed A Tazi
    Directorate of Epidemiology and Control Diseases, Health Ministry, Rabat, Morocco
    J Hypertens 21:897-903
    ..6%). CONCLUSIONS: The prevalence of cardiovascular risk factors was high in Morocco and it is necessary to increase action against the cardiovascular diseases and their risk factors.
  11. The relationship between albuminuria and hormone therapy in postmenopausal women
    Mamta Agarwal
    Department of Internal Medicine Nephrology, Wake Forest University Health Sciences, Winston Salem, NC 27157, USA
    Am J Kidney Dis 45:1019-25
    ..Other predictors of abnormal albuminuria included diabetes, blood pressure, and triglyceride level. CONCLUSION: Results of this study suggest that HT is associated with a reduction in urinary albumin excretion in postmenopausal women...
  12. Understanding obesity in the older person: prevalence and risk factors
    David Haslam
    National Obesity Forum, Luton
    Br J Community Nurs 13:115-6, 118, 120-2
    ..Clinical depression can be a manifestation of obesity. An overview of the prevalence and non-conservative clinical management is given...
  13. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany
    Elke Raum
    Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
    Pharmacoepidemiol Drug Saf 17:485-94
    ..85 (95%CI 1.19-2.89) and 2.59 (95%CI 1.41-4.74), respectively). CONCLUSIONS: For most elderly with diabetes cardiovascular risk factor management continues to be not in line with recommendations...
  14. Biological risk factors relevant to chronic disease in three ethnic groups in Taiwan: results from Li-Shin Outreaching Neighborhood Screening (LIONS A1)
    Huan Cheng Chang
    Department of Health Care Management, Chang Gung University, Taiwan
    Ethn Dis 18:228-34
    ..These findings can help design health policy for the early detection of chronic disease in different ethnic Chinese groups...
  15. Snoring and vascular risk factors and disease in a low-risk Chinese population: the Guangzhou Biobank Cohort Study
    G Neil Thomas
    Department of Community Medicine, and School of Public Health, The University of Hong Kong, Pokfulam
    Sleep 29:896-900
    ..CONCLUSION: Increasing snoring frequency was associated with an increasing prevalence of risk factors and self-reported vascular disease. Snoring may a useful marker for increased risk of vascular disease...
  16. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study
    Jie J Cao
    National Heart, Lung, and Blood Institute, National Institutes of Health, 10 Center Dr, MSC 1061, Bldg 10, Room B1D 416, Bethesda, MD 20892, USA
    Circulation 116:32-8
    ..Despite the significant associations of CRP and carotid atherosclerosis with CVD, these measures modestly improve the prediction of CVD outcomes after one accounts for the conventional risk factors...
  17. Vascular risk factors in the Swiss population
    Krassen Nedeltchev
    Dept. of Neurology, University Hospital of Bern, Freiburgstrasse 4, Switzerland
    J Neurol 252:1210-6
    ..OW and HT are by far most common and are likely to aggregate with each other. A small modification of these two factors would reduce the incidence of stroke and myocardial infarction significantly...
  18. The frequency and distribution of cardiovascular disease risk factors among Nebraska women enrolled in the WISEWOMAN screening program
    Shingairai A Feresu
    Department of Epidemiology, College of Public Health, University of Nebraska Medical Center, College of Public Health, Omaha, Nebraska 68198 4395, USA
    J Womens Health (Larchmt) 17:607-17
    ..Additionally, women on the lower end of the socioeconomic spectrum were less likely to return for repeat visits, suggesting that further investigation is needed to understand why these women fail to return for screening services...
  19. Risk factor identification and assessment in hypertension and diabetes (RIAHD) study
    S Skrtic
    Section of Clinical Pharmacology, Dept of Internal Medicine, Sahlgrenska University Hospital, Göteborg, Sweden
    Blood Press 15:367-74
    ..The RIAHD study emphasizes the importance of performing a more extended RF assessment in hypertensive patients with as well as without diabetes and/or micro/macroalbuminuria in order to expose the full RF profile...
  20. [Elderly patients in the family doctor's office. Almost every patient has more than one risk factor]
    D Einecke
    Deutsche Hochdruickliga e.V. DHL Deutsche Hypertonie Gesellschaft, Heidelberg
    MMW Fortschr Med 147:43-4, 46
  21. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome
    Keith C Ferdinand
    Heartbeats Life Center, New Orleans, LA, USA
    J Cardiometab Syndr 1:133-40
    ....
  22. The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes
    Thomas J Hoerger
    Research Triangle Institute International, USA
    J Manag Care Pharm 14:S2-14; quiz 15-6
    ..Various economic analyses indicate that global CMR should be reduced to control costs in this population. Newer antihyperglycemic agents with a favorable overall metabolic profile may offer a cost-effective approach to managing diabetes...
  23. Obesity and cardiovascular risk factors in Hong Kong Chinese
    Z S K Lee
    Department of Medicine and Therapeutics, The Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin
    Obes Rev 3:173-82
    ..Our data support using lower BMI and WC levels to define obesity and its associated health risks rather than using the criteria established from Caucasians who generally have larger body frames...
  24. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study
    Alain G Bertoni
    Division of Public Health Sciences, Department of Epidemiology and Prevention, Wake Forest University Health Sciences, Winston Salem, NC 27157, USA
    J Diabetes Complications 22:1-9
    ..CONCLUSION: These data demonstrate that numerous baseline characteristics are associated with suboptimal control of these cardiovascular risk factors among overweight and obese adults with diabetes...
  25. Alcohol consumption in the severely obese: relationship with the metabolic syndrome
    John B Dixon
    Monash University Department of Surgery, Alfred Hospital, Melbourne, Victoria, Australia
    Obes Res 10:245-52
    ..We would propose that light to moderate alcohol consumption should not be discouraged in the severely obese...
  26. Insulin and insulin resistance: impact on blood pressure and cardiovascular disease
    James R Sowers
    Division of Endocrinology, Diabetes and Hypertension, SUNY Downstate and VAMC, 450 Clarkson Avenue, Box 1205, Brooklyn, NY 11203, USA
    Med Clin North Am 88:63-82
    ..Additional therapeutic agents are currently being developed specifically to improve INS sensitivity and other CVD risk factors that are components of the cardiometabolic syndrome...
  27. The medical cost of cardiometabolic risk factor clusters in the United States
    Patrick W Sullivan
    Pharmaceuticals Outcomes Research Program, University of Colorado at Denver Health Sciences Center, 4200 East Ninth Avenue, C238, Denver, CO 80262, USA
    Obesity (Silver Spring) 15:3150-8
    ..S. independent of the cost of cardiovascular disease. Individuals, private insurers, Medicare, Medicaid, the Veterans Administration, and other payers all share this burden...
  28. Cardiovascular disease: strategies for risk assessment and modification
    Lynne T Braun
    Preventive Cardiology Center Associate Professor, College of Nursing, Rush University, Chicago, IL 60612, USA
    J Cardiovasc Nurs 21:S20-42; quiz S43-5
    ....
  29. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction
    Jan Basile
    Ralph H. Johnson VA Medical Center and Division of General Internal Medicine/Geriatrics, Medical University of South Carolina, Charleston, SC 29401, USA
    J Cardiometab Syndr 1:358-61
  30. Clinical implications of the metabolic syndrome
    Richard Ceska
    Centre for Preventive Cardiology, University General Hospital, U Nemocnice 1, Prague, 12808, Czech Republic
    Diab Vasc Dis Res 4:S2-4
    ..The atherogenic mixed dyslipidaemic profile associated with the metabolic syndrome is an important target for intervention to reduce the risk of type 2 diabetes and premature cardiovascular disease...
  31. Vascular risks and management of obesity in children and adolescents
    Courtney J Jolliffe
    School of Physical and Health Education, Queen's University, Kingston, Ontario, Canada
    Vasc Health Risk Manag 2:171-87
    ..While pharmacotherapy appears promising, additional evidence is needed, especially with respect to the long-term impact, before it becomes a widespread treatment option in the pediatric population...
  32. New insights into understanding cardiometabolic risk. Introduction
    Gregg C Fonarow
    Ahmanson-UCLA Cardiomyopathy Center, UCLA Preventive Cardiology Program, UCLA Division of Cardiology, Los Angeles, California, USA
    Rev Cardiovasc Med 8:S1-2
  33. Cardiovascular disease risk reduction in older adults
    Linda Klieman
    Cardiovascular Prevention Programs, Stanford Prevention Research Center, Stanford University School of Medicine, CA 94305 5705, USA
    J Cardiovasc Nurs 21:S27-39
    ..The most recent updates in the area of medical management, as well as updates of recommendations for lifestyle changes, including physical activity and dietary recommendations for older persons at risk, are presented in this article...
  34. Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence
    E O Talbott
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA
    Minerva Ginecol 56:27-39
    ..This review focuses on the controversy surrounding the potential relationship between cardiovascular disease outcomes and polycystic ovary syndrome...
  35. Non-invasive cardiovascular risk assessment in women with type 2 diabetes
    Sue Penckofer
    Loyola University Chicago, Neihoff School of Nursing, Maywood, IL 60153, USA
    J Vasc Nurs 23:2-7; quiz 8-9
    ..It may also be a feasible, non-invasive method for the detection and prevention of the macrovascular complications of diabetes...
  36. Influence of diabetes and cardiovascular disease on the long-term incidence of cataract: the Blue Mountains eye study
    Jennifer S L Tan
    Centre for Vision Research, Department of Ophthalmology and Westmead Millennium Institute, University of Sydney, Sydney, New South Wales, Australia
    Ophthalmic Epidemiol 15:317-27
    ..A cluster of metabolic abnormalities attributable to insulin resistance appears more likely to contribute to cataract formation than any individual cardiovascular risk factor alone...
  37. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia
    A H Barnett
    Birmingham Heartlands Hospital, Birmingham, UK
    J Psychopharmacol 21:357-73
    ..This review recommends a framework for the assessment, monitoring and management of patients with schizophrenia in the UK clinical setting...
  38. Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population
    Pasquale Strazzullo
    Department of Clinical and Experimental Medicine, Federico II University of Naples, 80131 Naples, Italy
    Metabolism 57:355-61
    ....
  39. [Obesity and cardiovascular morbidity]
    A Berg
    Abtlg. Prävention und Rehabilitative Sportmedizin, Klinikum der Albert-Ludwigs-Universität, 79106 Freiburg
    Dtsch Med Wochenschr 130:893-7
  40. Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes
    D Kapoor
    Centre for Diabetes and Endocrinology, Barnsley NHS Foundation Trust Hospital, Barnsley, UK
    Int J Androl 30:500-7
    ..This study has shown that ED is associated with low bioavailable and free testosterone levels, age, visceral adiposity and hypertension in type 2 diabetic men...
  41. [New theory turns the cause and effect principle on its head. Diabetes and hypertension--chicken and egg?]
    W Zidek
    Med. Klinik IV Endokrinologie und Nephrologie Charité-Universitätsklinik Berlin
    MMW Fortschr Med 146:44-5
  42. Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases
    R Perez Fernandez
    Department of Physiology, School of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
    J Hum Hypertens 21:366-73
    ..mass index was related to increased prevalence of HT and close associations were observed between HT and cardiovascular diseases. Our data also show a linear upward trend in blood pressure from normal glucose metabolism to diabetes ..
  43. Obesity in the elderly and its relationship with cardiovascular risk factors in Taiwan
    Kuo-Chin Huang
    Department of Family Medicine, National Taiwan University Hospital, N141, Institute of Biomedical Sciences, Academia Sinica, 128 Academy Road, Section 2, Taipei, 11529 Taiwan
    Obes Res 13:170-8
    ..However, none of them alone was a good screening tool for CVD risk factors. Therefore, how to apply AI prudently to screen elderly for CVD risk factors needs further research...
  44. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome
    Elvira Maria Mafaldo Soares
    Departamento de Tocoginecologia, Maternidade Escola Januário Cicco, Universidade Federal do Rio Grande do Norte, Natal RN, Brazil
    Fertil Steril 89:649-55
    ..Thus, these women are at increased risk of diabetes mellitus and cardiovascular disease...
  45. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults
    M Dalton
    International Diabetes Institute, Melbourne, Caulfield, Victoria, Australia
    J Intern Med 254:555-63
    ..Given the difficulty of using age-adjusted associations in the clinical setting, these results suggest that given appropriate cut-off points, WHR is the most useful measure of obesity to use to identify individuals with CVD risk factors...
  46. Cultural factors and patients' adherence to lifestyle measures
    Maleka Serour
    Family Practice Specialty Training Program FPSTP, Capital Health Region, Hawalli 32056, Kuwait
    Br J Gen Pract 57:291-5
    ..Additional cultural and demographic variables need to be considered to improve adherence to lifestyle measures...
  47. Body mass index (BMI) and waist circumference (WC) as screening tools for cardiovascular risk factors in Guadeloupean women
    Lydia Foucan
    Département d Information Médicale et de Santé Publique, French West Indies, CHU de Pointe à Pitre, Guadeloupe
    J Clin Epidemiol 55:990-6
    ..Waist circumference, a practical tool that had a higher discriminant ability than BMI in identifying presence or absence of all these risk factors, appears as the best screening tool in this population...
  48. Associations of community-based health education programs with food habits and cardiovascular disease risk factors among Native Americans with diabetes: the inter-tribal heart project, 1992 to 1994
    Sujata L Archer
    Department of Preventive Medicine, Northwestern University Medical School, Chicago, Ill, USA
    J Am Diet Assoc 102:1132-5
  49. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women
    D Creagh
    Department of Epidemiology and Public Health, University College, Cork, Ireland
    Ir Med J 95:298-301
    ..The findings emphasise the scale of the CVD epidemic in Ireland and the need for ongoing monitoring of risk factors at the population level and the need to develop preventive strategies at both the clinical and societal level...
  50. Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey 2001
    S M Kim
    Department of Family Medicine, Korea University College of Medicine, Seoul, Korea
    Diabetes Care 29:226-31
    ..These results emphasize the need to develop an urgent public program to improve the detection, prevention, and treatment of diabetes...
  51. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study
    Marco Comaschi
    Department of Internal Medicine, West Genoa Hospital, Genova, Italy
    Nutr Metab Cardiovasc Dis 15:204-11
    ..Only a stricter adherence to the existing guidelines and a much stronger attention to the attainment of the desired therapeutic goals will allow a decrease in morbidity and mortality as well as in the costs related to diabetes...
  52. Obesity and pre-hypertension in family medicine: implications for quality improvement
    James E Rohrer
    Department of Family Medicine, Mayo Clinic, Rochester, Minnesota USA
    BMC Health Serv Res 7:212
    ..Weight loss intervention for obese patients, including patient education or referral to weight loss programs, might be effective for prevention of pre-hypertension and thus should be considered as a potential quality indicator...
  53. Impact of sex-specific body composition on cardiovascular risk factors: the Hong Kong Cardiovascular Risk Factor Study
    G Neil Thomas
    Department of Community Medicine, The University of Hong Kong, Pokfulam, Hong Kong
    Metabolism 55:563-9
    ..Increasing adjusted waist circumference was associated with increased risk of hypertension and diabetes in Chinese and dyslipidemia in women only...
  54. Cohort differences in obesity-related health indicators among 70-year olds with special reference to gender and education
    Claudia Cabrera
    Nordic School of Public Health, Sahlgrenska Academy, Göteborg University, 30 Göteborg, Sweden
    Eur J Epidemiol 18:883-90
    ..In conclusion, secular trends in many obesity-related health indicators among 70-year old Swedish cohorts were dependent on both gender and socio-economic factors...